Arteris Announces New Employment Inducement Grants
Arteris (Nasdaq:AIP) announced that its compensation committee granted an aggregate of 477,208 restricted stock units (RSUs) as inducement awards to 25 newly hired employees under the company’s 2022 Employee Inducement Incentive Plan.
Rhea-AI Summary
Arteris (Nasdaq:AIP) announced that its compensation committee granted an aggregate of 477,208 restricted stock units (RSUs) as inducement awards to 25 newly hired employees under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4), approved by the board of directors, with an effective RSU grant date of January 15, 2026. The awards are intended as employment inducements for recent hires.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AIP
In the Jan 20 session, AIP declined 4.72%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- RSU inducement grants
- 477,208 RSUs
- Aggregate awards to 25 new employees under 2022 Inducement Plan
- Employees granted
- 25 employees
- Recipients of inducement RSU awards effective Jan 15, 2026
- Shelf registration capacity
- $200,000,000
- Total potential offerings under S-3 shelf registration
- ATM program size
- $75,000,000
- Common stock that may be sold via at-the-market program
- Sales agent fee
- 3.0%
- Jefferies’ commission on gross proceeds from ATM sales
- Q3 2025 revenue
- $17.4M
- Q3 2025 results, +18% year-over-year
- Q3 2025 ACV+royalties
- $74.9M
- Q3 2025, +24% year-over-year
- Q3 2025 RPO
- $104.7M
- Q3 2025, +34% year-over-year and first time above $100M
Historical Context
-
Closed Cycuity acquisition, adding semiconductor cybersecurity assurance technology.
-
Definitive agreement to acquire Cycuity and expand security-focused portfolio.
-
Black Sesame licensed Ncore 3 and FlexNoC 5 for next-gen automotive SoCs.
-
Blaize adopted FlexNoC 5 IP to enhance scalable edge AI platform.
-
Q3 2025 growth metrics and updated Q4/full-year 2025 guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
restricted stock units financial
rsus financial
nasdaq listing rule 5635(c)(4) regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMPBELL, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the compensation committee of the company’s board of directors has granted an aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
The effective RSU grant date was January 15, 2026 and it was approved by the company’s board of directors.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Investor Contacts:
Arteris
Nick Hawkins
IR@arteris.com
Sapphire Investor Relations, LLC
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com
Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.com
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.